Back
Arca Continental SAB de CV Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
65
EMBVF
Arca Continental SAB de CV
Last Price:
$10.55
Seasonality Move:
9.06%
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
$105.55
Seasonality Move:
5.14%
Buy
65
Arca Continental SAB de CV (EMBVF)
is a Buy
Is Arca Continental SAB de CV a Buy, Sell or Hold?
-
The current Arca Continental SAB de CV [EMBVF] share price is $10.44. The Score for EMBVF is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
EMBVF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $106.12. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EMBVF Stock Price Chart
What is Arca Continental SAB de CV's stock price today?
-
The Arca Continental SAB de CV share price today is $10.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EMBVF is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $106.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
EMBVF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 70.02 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.85 - 10.01) | Buy |
Bollinger Bands (100): | (8.41 - 9.43) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.32 | Sell |
Relative Strength Index (14 RSI): | 35.13 | Sell |
Chaikin Money Flow: | -665542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (109.06 - 117.26) | Sell |
Bollinger Bands (100): | (113.14 - 127.52) | Sell |
EMBVF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.16 | Buy |
20-day SMA: | 9.6 | Buy |
50-day SMA: | 9.05 | Buy |
200-day SMA: | 9.32 | Buy |
8-day EMA: | 10.06 | Buy |
20-day EMA: | 9.68 | Buy |
50-day EMA: | 9.25 | Buy |
200-day EMA: | 9.29 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 107.99 | Sell |
20-day SMA: | 112.1 | Sell |
50-day SMA: | 118.2 | Sell |
200-day SMA: | 128.11 | Sell |
8-day EMA: | 108.31 | Sell |
20-day EMA: | 111.56 | Sell |
50-day EMA: | 116.18 | Sell |
200-day EMA: | 122.74 | Sell |
Arca Continental SAB de CV Earnings Growth & EMBVF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.05 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
Arca Continental SAB de CV Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |